Skip to main content
OpenTrials

Clinical trial condition

Rubella

Explore clinical trials studying Rubella. Study availability and eligibility vary by location and protocol.

68 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Rubella trial results

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

NCT00751348

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Bucheon-si, South Korea
  • GSK Investigational Site Daejeon, South Korea
  • GSK Investigational Site Gwangju, South Korea
  • GSK Investigational Site GyeongSangNam-do, South Korea
View all 13 locations
View Trial Details
Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

NCT02058563

Conditions
Infections, Measles, Mononegavirales Infections, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Miami, Florida, United States
View all 17 locations
View Trial Details
Completed

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

NCT03160820

Conditions
Adverse Event Following Immunisation, Infections, Measles, +15 more
Locations
  • Hebei Provincial Center for Disease Control and Prevention Shijiazhuang, Hebei, China
  • Inner Mongolia Center for Disease Control and Prevention Hohhot, Inner Mongolia, China
  • Shanxi Provincial Center for Disease Control and Prevention Taiyuan, Shanxi, China
  • Tianjin Center for Disease Control and Prevention Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions